Patents by Inventor Janette Thomas

Janette Thomas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FORMULATION
    Publication number: 20220119819
    Abstract: The present invention relates to a new formulation of the oligonucleotide of SEQ ID NO: 1.
    Type: Application
    Filed: January 6, 2022
    Publication date: April 21, 2022
    Inventors: Toby Wilson Waterworth, Lorin Johnson, Janette Thomas, Michael Webb
  • Formulation
    Patent number: 11220690
    Abstract: The present invention relates to a new formulation of the oligonucleotide of SEQ ID NO:1.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: January 11, 2022
    Assignee: Atlantic Pharmaceuticals (Holdings) LTD
    Inventors: Toby Wilson Waterworth, Lorin Johnson, Janette Thomas, Michael Webb
  • NEW THERAPEUTIC USES
    Publication number: 20190388459
    Abstract: The present invention related to a new therapeutic uses the molecule set out as SEQ ID NO: 1.
    Type: Application
    Filed: January 8, 2018
    Publication date: December 26, 2019
    Inventors: Toby Waterworth, Lorin Johnson, Janette Thomas, Michael Webb
  • NEW FORMULATION
    Publication number: 20190367927
    Abstract: The present invention relates to a new formulation of the oligonucleotide of SEQ ID NO:1.
    Type: Application
    Filed: January 8, 2018
    Publication date: December 5, 2019
    Inventors: Toby Wilson Waterworth, Lorin Johnson, Janette Thomas, Michael Webb